Your browser is no longer supported. Please, upgrade your browser.
Settings
OCGN [NASD]
Ocugen, Inc.
Index- P/E- EPS (ttm)-0.27 Insider Own0.50% Shs Outstand195.57M Perf Week10.91%
Market Cap1.62B Forward P/E31.98 EPS next Y0.25 Insider Trans-53.86% Shs Float193.90M Perf Month10.75%
Income-47.30M PEG- EPS next Q-0.04 Inst Own28.80% Short Float26.34% Perf Quarter20.70%
Sales0.04M P/S38066.60 EPS this Y79.00% Inst Trans123.75% Short Ratio2.85 Perf Half Y-11.10%
Book/sh0.60 P/B13.22 EPS next Y189.30% ROA-83.70% Target Price7.90 Perf Year2218.71%
Cash/sh0.57 P/C14.03 EPS next 5Y- ROE-95.10% 52W Range0.25 - 18.77 Perf YTD333.33%
Dividend- P/FCF- EPS past 5Y70.80% ROI- 52W High-57.75% Beta4.52
Dividend %- Quick Ratio25.10 Sales past 5Y- Gross Margin- 52W Low3070.73% ATR0.54
Employees15 Current Ratio25.10 Sales Q/Q- Oper. Margin- RSI (14)55.63 Volatility10.26% 6.50%
OptionableYes Debt/Eq0.01 EPS Q/Q31.40% Profit Margin- Rel Volume0.81 Prev Close7.54
ShortableYes LT Debt/Eq0.01 EarningsAug 06 BMO Payout- Avg Volume17.91M Price7.93
Recom2.60 SMA206.18% SMA508.45% SMA20017.43% Volume14,562,612 Change5.17%
Jul-26-21Initiated Noble Capital Markets Outperform
Jun-11-21Downgrade ROTH Capital Buy → Neutral $10 → $6
May-07-21Downgrade Cantor Fitzgerald Overweight → Neutral
Feb-09-21Downgrade Chardan Capital Markets Buy → Neutral $0.70 → $13
Feb-04-21Upgrade H.C. Wainwright Neutral → Buy $4.50
Sep-17-21 04:52PM  
11:17AM  
Sep-15-21 12:33PM  
08:34AM  
Sep-13-21 02:10PM  
Sep-10-21 10:50PM  
Sep-07-21 05:22PM  
Sep-02-21 02:25PM  
Aug-30-21 11:46AM  
Aug-27-21 02:55PM  
Aug-25-21 09:12AM  
Aug-20-21 04:34PM  
Aug-19-21 09:49AM  
Aug-17-21 12:25PM  
11:48AM  
11:00AM  
09:42AM  
09:19AM  
08:00AM  
Aug-16-21 06:02PM  
04:25PM  
01:20PM  
11:44AM  
11:40AM  
10:30AM  
10:00AM  
Aug-15-21 12:38PM  
11:50AM  
10:10AM  
Aug-13-21 08:00PM  
07:18PM  
05:50PM  
04:58PM  
04:38PM  
04:10PM  
01:00PM  
12:45PM  
11:45AM  
11:45AM  
11:08AM  
11:00AM  
Aug-12-21 05:35PM  
03:59PM  
11:20AM  
11:03AM  
10:00AM  
09:36AM  
08:00AM  
Aug-11-21 08:25PM  
08:17PM  
08:00PM  
07:47PM  
12:10PM  
11:00AM  
11:00AM  
10:10AM  
08:38AM  
Aug-10-21 02:14PM  
12:45PM  
12:00PM  
11:00AM  
11:00AM  
10:45AM  
09:43AM  
Aug-09-21 01:00PM  
11:55AM  
11:45AM  
11:30AM  
11:00AM  
10:15AM  
09:50AM  
Aug-06-21 08:01PM  
04:01PM  
02:00PM  
12:32PM  
11:52AM  
11:15AM  
10:37AM  
08:32AM  
07:32AM  
Aug-05-21 02:10PM  
11:06AM  
06:28AM  
05:40AM  
Aug-04-21 08:40PM  
08:00PM  
02:00PM  
01:20PM  
01:00PM  
12:50PM  
12:00PM  
11:30AM  
11:03AM  
11:00AM  
05:34AM  
Aug-03-21 10:25PM  
01:30PM  
01:30PM  
12:00PM  
11:33AM  
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Musunuri ShankarChief Executive OfficerSep 15Option Exercise0.33125,00041,250531,000Sep 17 04:01 PM
Musunuri ShankarChief Executive OfficerSep 15Sale7.52125,000940,000406,000Sep 17 04:01 PM
Subramanian SanjayChief Financial OfficerAug 16Option Exercise0.3430,00010,20075,591Aug 18 04:01 PM
Subramanian SanjayChief Financial OfficerAug 16Sale7.2230,000216,60045,591Aug 18 04:01 PM
Kompella UdayDirectorJul 30Option Exercise1.8310,00018,300560,674Jul 30 05:28 PM
Kompella UdayDirectorJul 30Sale6.8110,00068,072550,674Jul 30 05:28 PM
Kumar RameshDirectorJul 19Option Exercise0.517,5003,8257,500Jul 21 04:04 PM
Kumar RameshDirectorJul 19Sale6.407,50048,0000Jul 21 04:04 PM
Subramanian SanjayChief Financial OfficerJul 15Option Exercise0.3431,08610,56976,677Jul 16 04:01 PM
Subramanian SanjayChief Financial OfficerJul 15Sale6.7031,086208,27645,591Jul 16 04:01 PM
Kompella UdayDirectorJun 25Option Exercise1.8310,00018,300560,674Jun 25 04:17 PM
Kompella UdayDirectorJun 25Sale8.1310,00081,345550,674Jun 25 04:17 PM
Subramanian SanjayChief Financial OfficerJun 15Option Exercise0.3431,00010,54076,591Jun 17 05:25 PM
Subramanian SanjayChief Financial OfficerJun 15Sale7.0031,000217,00045,591Jun 17 05:25 PM
Potti ManishDirectorJun 15Sale8.8668,185604,11991,124Jun 17 05:23 PM
Musunuri ShankarChief Executive OfficerJun 08Option Exercise0.3322,8007,524428,800Jun 09 07:22 PM
Musunuri ShankarChief Executive OfficerJun 08Sale10.9822,800250,344406,000Jun 09 07:22 PM
Musunuri ShankarChief Executive OfficerJun 07Option Exercise0.337,7582,560413,758Jun 09 07:22 PM
Castillo KirstenDirectorJun 07Sale10.0010,000100,00065,000Jun 09 07:21 PM
Musunuri ShankarChief Executive OfficerJun 07Sale10.947,75884,873406,000Jun 09 07:22 PM
Kompella UdayDirectorMay 28Option Exercise1.887,19113,519557,865Jun 01 06:10 AM
Kompella UdayDirectorMay 28Sale8.827,19163,417550,674Jun 01 06:10 AM
Fernandes PrabhavathiDirectorMay 25Option Exercise0.9333,50031,08019,500May 27 04:07 PM
Fernandes PrabhavathiDirectorMay 25Sale8.2033,500274,7550May 27 04:07 PM
Subramanian SanjayChief Financial OfficerMay 14Option Exercise0.3431,00010,54076,591May 14 04:58 PM
Subramanian SanjayChief Financial OfficerMay 14Sale8.1831,000253,67345,591May 14 04:58 PM
Tammara VijaySenior Vice PresidentMay 04Option Exercise0.8115,71112,7556,500May 05 08:15 PM
Tammara VijaySenior Vice PresidentMay 04Sale13.6815,711214,9540May 05 08:15 PM
Musunuri ShankarChief Executive OfficerMay 03Option Exercise0.51195,80999,863601,809May 03 09:00 PM
Tammara VijaySenior Vice PresidentMay 03Option Exercise0.464,3171,9864,317May 03 08:53 PM
Potti ManishDirectorMay 03Sale15.0260,000901,20063,429May 05 08:13 PM
Potti ManishDirectorMay 03Sale15.0128,000420,2800May 05 08:13 PM
Tammara VijaySenior Vice PresidentMay 03Sale16.004,31769,0720May 03 08:53 PM
Kompella UdayDirectorMay 03Sale15.0150,000750,500550,674May 03 09:05 PM
Musunuri ShankarChief Executive OfficerMay 03Sale14.24195,8092,788,320406,000May 03 09:00 PM
Kompella UdayDirectorApr 30Option Exercise0.5120,00010,200620,674May 03 09:05 PM
Kompella UdayDirectorApr 30Sale11.5620,000231,200600,674May 03 09:05 PM
Tammara VijaySenior Vice PresidentApr 29Option Exercise0.7529,99122,44212,880May 03 08:53 PM
Subramanian SanjayChief Financial OfficerApr 29Option Exercise2.197,99017,49853,581May 03 09:06 PM
Subramanian SanjayChief Financial OfficerApr 29Sale10.987,99087,73045,591May 03 09:06 PM
Tammara VijaySenior Vice PresidentApr 29Sale10.9729,991328,8810May 03 08:53 PM
Kompella UdayDirectorApr 26Sale11.70350,0004,095,000600,674Apr 28 06:52 PM
Kumar RameshDirectorApr 19Option Exercise0.517,5003,8257,500Apr 21 04:16 PM
Kumar RameshDirectorApr 19Sale5.337,50039,9750Apr 21 04:16 PM
Potti ManishDirectorMar 05Option Exercise0.8428,00023,52028,000Mar 08 08:38 PM
Subramanian SanjayChief Financial OfficerJan 29Option Exercise0.5135,59118,15145,591Feb 01 05:31 PM